Elderly-onset rheumatoid arthritis is a unique disease subset associated with poor overall outcomes: Response to the letter by Haroon and Ayamer
- PMID: 33358004
- DOI: 10.1016/j.semarthrit.2020.09.015
Elderly-onset rheumatoid arthritis is a unique disease subset associated with poor overall outcomes: Response to the letter by Haroon and Ayamer
Conflict of interest statement
Declaration of Competing Interest VCR reports personal fees and non-financial support from Pfizer and Janssen; non-financial support from Merck Sharp and Dohme, Lilly and Roche, outside the submitted work. JEF reports grants and personal fees from AbbVie, Merck Sharp and Dohme, Pfizer, Roche, UCB Pharma, Janssen, Novartis and Sanofi, outside the submitted work. CP reports grants and personal fees from Abbott/AbbVie, Astellas, AstraZeneca/MedImmune, Bristol-Myers Squibb, Janssen/Johnson & Johnson, Merck Sharp and Dohme, Pfizer, Roche/Genentech/Chugai and UCB Pharma, outside the submitted work.
Comment on
-
Treatment-resistant synovitis and radiographic progression are increased in elderly-onset rheumatoid arthritis patients: findings from a prospective observational longitudinal early arthritis cohort study.Semin Arthritis Rheum. 2020 Aug;50(4):735-743. doi: 10.1016/j.semarthrit.2020.03.018. Epub 2020 May 15. Semin Arthritis Rheum. 2020. PMID: 32531503
-
Elderly onset of rheumatoid arthritis is more common in males, and requires maintenance of low-dose corticosteroids along with the combination of disease modifying anti rheumatic agents.Semin Arthritis Rheum. 2021 Oct;51(5):e10. doi: 10.1016/j.semarthrit.2020.09.017. Epub 2020 Dec 18. Semin Arthritis Rheum. 2021. PMID: 33358003 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical